Intensive insulin treatment induces insulin resistance in diabetic rats by impairing glucose metabolism-related mechanisms in muscle and liver

Journal of Endocrinology

Volumn 211, Issue 1, 2011, Pages 55-64

  Okamoto, Maristela Mitiko ^a   Anhê, Gabriel Forato ^b   Sabino Silva, Robinson ^a   Marques, Milano Felipe Dos Santos Ferreira ^a   Freitas, Helayne Soares ^a   Mori, Rosana Cristina Tieko ^a   Melo, Karla Fabiana S ^a   Machado, Ubiratan Fabres ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE 6 PHOSPHATASE; GLUCOSE TRANSPORTER 4; ISOPHANE INSULIN; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); SODIUM CHLORIDE; ALLOXAN; ANTIDIABETIC AGENT; FORKHEAD TRANSCRIPTION FACTOR; FOXO1 PROTEIN, RAT; GLUCOSE; GLYCOGEN; INSULIN; NERVE PROTEIN; PHOSPHOENOLPYRUVATE CARBOXYLASE KINASE; PROTEIN SERINE THREONINE KINASE; SLC2A4 PROTEIN, RAT;

ALLOXAN DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MEGADOSE; GLUCOSE METABOLISM; GLYCEMIC CONTROL; HYPERINSULINEMIA; HYPOINSULINEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRACELLULAR SIGNALING; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SKELETAL MUSCLE; WISTAR RAT; ANIMAL; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DOSE RESPONSE; EXPERIMENTAL DIABETES MELLITUS; LIVER; METABOLISM; PHYSIOLOGY;

ALLOXAN; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FORKHEAD TRANSCRIPTION FACTORS; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; GLUCOSE-6-PHOSPHATASE; GLYCOGEN; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; LIVER; MALE; MUSCLE, SKELETAL; NERVE TISSUE PROTEINS; PROTEIN-SERINE-THREONINE KINASES; RATS; RATS, WISTAR;

EID: 80555143102     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-11-0105     Document Type: Article

References (50)

1. Altomonte J, Richter A, Harbaran S, Suriawinata J, Nakae J, Thung SN, Meseck M, Accili D & Dong H 2003 Inhibition of Foxo1 function is associated with improved fasting glycemia in diabetic mice. American Journal of Physiology 285 E718-E728. (doi:10.1152/ajpendo.00156.2003)
2. Andjelković M, Alessi DR, Meier R, Fernandez A, Lamb NJ, Frech M, Cron P, Cohen P, Lucocq JM & Hemmings BA 1997 Role of translocation in the activation and function of protein kinase B. Journal of Biological Chemistry 272 31515-31524. (doi:10.1074/jbc.272.50.31515)
3. Andrews NC & Faller DV 1991 A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Research 19 2499. (doi:10.1093/nar/19.9.2499)
4. Anhê GF, Hirabara SM, Turrer TC, Caperuto LC, Anhê FF, Ribeiro LM, Marçal AC, Carvalho CR, Curi R, Machado UF et al. 2007 Postpartum glycemic homeostasis in early lactating rats is accompanied by transient and specific increase of soleus insulin response through IRS2/AKT pathway. American Journal of Physiology 292 R2225-R2233. (doi:10.1152/ajpregu. 00902.2006)
5. Barthel A & Schmoll D 2003 Novel concepts in insulin regulation of hepatic gluconeogenesis. American Journal of Physiology 285 E685-E692. (doi:10. 1152/ajpendo.00253.2003)
6. Berger J, Biswas C, Vicario PP, Strout HV, Saperstein R & Pilch PF 1989 Decreased expression of the insulin-responsive glucose transporter in diabetes and fasting. Nature 340 70-72. (doi:10.1038/340070a0)
7. Biggs WH III, Meisenhelder J, Hunter T, Cavenee WK & Arden KC 1999 Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1. PNAS 96 7421-7426. (doi:10.1073/pnas.96.13.7421)
8. Bitar MS 2001 Co-administration of etomoxir and RU-486 mitigates insulin resistance in hepatic and muscular tissues of STZ-induced diabetic rats. Hormone and Metabolic Research 33 577-584. (doi:10.1055/s-2001-17903)
9. BjörnholmM& Zierath JR 2005 Insulin signal transduction in human skeletal muscle: identifying the defects in type II diabetes. Biochemical Society Transactions 33 354-357. (doi:10.1042/BST0330354)
10. Blondel O & Portha B 1989 Early appearance of in vivo insulin resistance in adult streptozotocin-injected rats. Diabetes and Metabolism 15 382-387.
11. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J & Greenberg ME 1999 Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96 857-868. (doi:10.1016/S0092-8674(00)80595-4)
12. Burcelin R, Eddouks M, Maury J, Kande J, Assan R & Girard J 1995 Excessive glucose production, rather than insulin resistance, accounts for hyperglycaemia in recent-onset streptozotocin-diabetic rats. Diabetologia 38 283-290. (doi:10.1007/BF00400632)
13. Camps M, Castelló A, Muñoz P, Monfar M, Testar X, Palacín M& Zorzano A 1992 Effect of diabetes and fasting on GLUT-4 (muscle/fat) glucosetransporter expression in insulin-sensitive tissues. Heterogeneous response in heart, red and white muscle. Biochemical Journal 282 765-772.
14. Carvalho E, Kotani K, Peroni OD & Kahn BB 2005 Adipose-specific overexpression of GLUT4 reverses insulin resistance and diabetes in mice lacking GLUT4 selectively in muscle. American Journal of Physiology 289 E551-E561. (doi:10.1152/ajpendo.00116.2005)
15. DeFronzo RA 1997 Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidaemia and atherosclerosis. Netherlands Journal of Medicine 50 191-197. (doi:10.1016/S0300-2977(97)00012-0)
16. Diabetes Control and Complications Trial Research Group 2001 Influence of intensive diabetes treatment on body weight and composition of adults with type 1 diabetes in the Diabetes Control and Complications Trial. Diabetes Care 24 1711-1721. (doi:10.2337/diacare.24.10.1711)
17. Federiuk IF, Casey HM, Quinn MJ, Wood MD &Ward WK 2004 Induction of type-1 diabetes mellitus in laboratory rats by use of alloxan: route of administration, pitfalls, and insulin treatment. Comparative Medicine 54 252-257.
18. Ferguson RE, Carroll HP, Harris A, Maher ER, Selby PJ & Banks RE 2005 Housekeeping proteins: a preliminary study illustrating some limitations as useful references in protein expression studies. Proteomics 5 566-571. (doi:10.1002/pmic.200400941)
19. Gerich JE 2010 Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implications. Diabetic Medicine 27 136-142. (doi:10.1111/j.1464-5491.2009.02894.x)
20. Girard J 2006 Insulin's effect on the liver: "direct or indirect"? Continues to be the question Journal of Clinical Investigation 116 302-324. (doi:10.1172/JCI27743)
21. Guo S, Copps KD, Dong X, Park S, Cheng Z, Pocai A, Rossetti L, Sajan M, Farese RV & White MF 2009 The Irs1 branch of the insulin signaling cascade plays a dominant role in hepatic nutrient homeostasis. Molecular and Cellular Biology 29 5070-5083. (doi:10.1128/MCB.00138-09)
22. Huang S & Czech MP 2007 The GLUT4 glucose transporter. Cell Metabolism 5 237-252. (doi:10.1016/j.cmet.2007.03.006)
23. Kainulainen H, Komulainen J, Joost HG & Vihko V 1994 Dissociation of the effects of training on oxidative metabolism, glucose utilization and GLUT4 levels in skeletal muscle of streptozotocin-diabetic rats. Pflügers Archiv 427 444-449. (doi:10.1007/BF00374259)
24. Kubota N, Tobe K, Terauchi Y, Eto K, Yamauchi T, Suzuki R, Tsubamoto Y, Komeda K, Nakano R, Miki H et al. 2000 Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia. Diabetes 49 1880-1889. (doi:10. 2337/diabetes.49.11.1880)
25. Kubota N, Kubota T, Itoh S, Kumagai H, Kozono H, Takamoto I, Mineyama T, Ogata H, Tokuyama K, Ohsugi M et al. 2008 Dynamic functional relay between insulin receptor substrate 1 and 2 in hepatic insulin signaling during fasting and feeding. Cell Metabolism 8 49-64. (doi:10.1016/j.cmet. 2008.05.007)
26. Ledwig D, Müller H, Bischoff H & Eckel J 2002 Early acarbose treatment ameliorates resistance of insulin-regulated GLUT4 trafficking in obese Zucker rats. European Journal of Pharmacology 445 141-148. (doi:10.1016/S0014-2999(02)01714-4)
27. Lenzen S 2008 The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia 51 216-226. (doi:10.1007/s00125-007-0886-7)
28. Liu HY, Cao SY, Hong T, Han J, Liu Z & Cao W 2009 Insulin is a stronger inducer of insulin resistance than hyperglycemia in mice with type 1 diabetes mellitus (T1DM). Journal of Biological Chemistry 284 27090-27100. (doi:10.1074/jbc.M109.016675)
29. Liu J, Wu X, Franklin JL, Messina JL, Hill HS, Moellering DR, Walton RG, Martin M & Garvey WT 2010 Mammalian Tribbles homolog 3 impairs insulin action in skeletal muscle: role in glucose-induced insulin resistance. American Journal of Physiology 298 E565-E576. (doi:10.1152/ajpendo. 00467.2009)
30. Machado UF, Shimizu I & Saito M 1994 Reduced content and preserved translocation of glucose transporter (GLUT4) in white adipose tissue of obese mice. Physiology & Behaviour 55 621-625. (doi:10.1016/0031-9384(94)90035-3)
31. Meyer C, Stumvoll M, Nadkami V, Dostou J, Mitrakou A & Gerich J 1998 Abnormal renal and hepatic glucose metabolism in type 2 diabetes mellitus. Journal of Clinical Investigation 102 619-624. (doi:10.1172/JCI2415)
32. Michael MD, Kulkarni RN, Postic C, Previs SF, Shulman GI, Magnuson MA & Kahn CR 2000 Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Molecular Cell 6 87-97. (doi:10.1016/S1097-2765(05)00015-8)
33. Mori RC, Hirabara SM, Hirata AE, Okamoto MM & Machado UF 2008 Glimepiride as insulin sensitizer: increased liver and muscle responses to insulin. Diabetes, Obesity & Metabolism 10 596-600. (doi:10.1111/j.1463-1326.2008.00870.x)
34. Mounier C & Posner BI 2006 Transcriptional regulation by insulin: from receptor to the gene. Canadian Journal of Physiology and Pharmacology 115 713-724. (doi:10.1139/y05-152)
35. Nakae J, Kitamura T, Silver DL & Accili D 2001 The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression. Journal of Clinical Investigation 108 1359-1367. (doi:10.1172/JCI200112876)
36. O'Brien RM, Streeper RS, Ayala JE, Stadelmaier BT & Hornbuckle LA 2001 Insulin-regulated gene expression. Biochemical Society Transactions 29 552-558. (doi:10.1042/BST0290552)
37. Pfaffl MW 2001 A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Research 29 e45. (doi:10.1093/nar/29.9.e45)
38. Purnell JQ, Hokanson JE, Marcovina SM, Steffes MW, Cleary PA & Brunzell JD 1998 Effect of excessive weight gain with intensive therapy of type 1 diabetes on lipid levels and blood pressure: results from the DCCT. Diabetes Control and Complications Trial. Journal of the American Medical Association 280 140-146. (doi:10.1001/jama. 280.2.140)
39. Shepherd PR, Gnudi L, Tozzo E, Yang H, Leach F & Kahn BB 1993 Adipose cell hyperplasia and enhanced glucose disposal in transgenic mice overexpressing GLUT4 selectively in adipose tissue. Journal of Biological Chemistry 268 22243-22246.
40. Sivitz WI, DeSautel SL, Kayano T, Bell GI & Pessin JE 1989 Regulation of glucose transporter messenger RNA in insulin-deficient states. Nature 340 72-74. (doi:10.1038/340072a0)
41. Taniguchi CM, Ueki K & Kahn R 2005 Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism. Journal of Clinical Investigation 115 718-727. (doi:10.1172/JCI200523187)
42. Taniguchi CM, Emanuelli B & Kahn CR 2006 Critical nodes in signalling pathways: insights into insulin action. Nature Reviews. Molecular Cell Biology 7 85-96. (doi:10.1038/nrm1837)
43. Uruska A, Araszkiewicz A, Zozulinska-Ziolkiewicz D, Uruski P & Wierusz- Wysocka B 2010 Insulin resistance is associated with microangiopathy in type 1 diabetic patients treated with intensive insulin therapy from the onset of disease. Experimental and Clinical Endocrinology and Diabetes 118 478-484. (doi:10.1055/s-0030-1249635)
44. Valverde AM, Burks DJ, Fabregat I, Fisher TL, Carretero J, White MF&Benito M 2003 Molecular mechanisms of insulin resistance in IRS-2-deficient hepatocytes. Diabetes 52 2239-2248. (doi:10.2337/diabetes.52.9.2239)
45. Van Der Heide LP, Hoekman MF & Smidt MP 2004 The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation. Biochemical Journal 380 297-309. (doi:10.1042/BJ20040167)
46. Vidal-Puig A & O'Rahilly S 2001 Metabolism: controlling the glucose factory. Nature 13 125-126. (doi:10.1038/35093198)
47. Wallberg-Henriksson H & Zierath JR 2001 GLUT4: a key player regulating glucose homeostasis? Insights from transgenic and knockout mice Molecular Membrane Biology 18 205-211. (doi:10.1080/09687680 110072131)
48. Withers DJ, Gutierrez JS, Towery H, Burks DJ, Ren JM, Previs S, Zhang Y, Bernal D, Pons S, Shulman GI et al. 1998 Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391 900-904. (doi:10.1038/36116)
49. Yeagley D, Guo S, Unterman T & Quinn PG 2001 Gene- and activationspecific mechanisms for insulin inhibition of basal and glucocorticoidinduced insulin-like growth factor binding protein-1 and phosphoenolpyruvate carboxykinase transcription. Roles of forkhead and insulin response sequences. Journal of Biological Chemistry 276 33705-33710. (doi:10.1074/jbc.M101215200)
50. Zanquetta MM, Nascimento ME, Mori RC, D'Agord Schaan B, Young ME & Machado UF 2006 Participation of beta-adrenergic activity in modulation of GLUT4 expression during fasting and refeeding in rats. Metabolism 55 1538-1545. (doi:10.1016/j.metabol.2006. 06.026)